We also found that the expression level of serum exosomal miR-940 could reflect the presence of lymph node metastasis in breast cancer patients and the expression level of serum exosomal HER2/neu in breast cancer patients, indicating its potential as a metastasis marker. Here, ERBB2 is linked to breast carcinoma.